Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence

Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence

Abstract Purpose Despite advances in surgical techniques and rehabilitation protocols, arthrofibrosis following total knee arthroplasty (TKA) still has poor outcomes. In the last decade, attention has been focused on the pathogenesis and cascade of events leading to the development of fibrosis. Curr...

Full description

Saved in:
Bibliographic Details
Main Authors: Giuseppe Anzillotti, Andreas H. Gomoll, Pietro Conte, Alberto Bulgarelli, Paolo Queirazza, Maurilio Marcacci, Elizaveta Kon, Berardo Di Matteo
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Journal of Experimental Orthopaedics
Subjects:
aldosterone
angiotensin
arthrofibrosis
knee
losartan
RAAS inhibitors
Online Access:https://doi.org/10.1002/jeo2.70089
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jeo2.70089

Similar Items